UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549
                                  ------------

                                  SCHEDULE 13D
                                 (Rule 13d-101)

         INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-
             1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a)
                                (Amendment No. )

                                  Aspyra, Inc.
       ------------------------------------------------------------------
                                (Name of Issuer)

                           COMMON STOCK, NO PAR VALUE
       ------------------------------------------------------------------
                         (Title of Class of Securities)

                                    04538V104
       ------------------------------------------------------------------
                                 (CUSIP Number)

                                 Jay Weil, Esq.
                                27 Viewpoint Road
                             Wayne, New Jersey 07470
                             Tel. No. (973) 633-5072
       ------------------------------------------------------------------
                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                  May 17, 2006
       ------------------------------------------------------------------
             (Date of Event Which Requires Filing of This Statement)


----------------------

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|

Note: Six copies of this statement, including all exhibits, should be filed with
      the Commission. See Rule 13d-1 (a) for other parties to whom copies are to
      be sent. (Continued on the following pages)






CUSIP No.  04538V104
           ---------


1    NAMES OF REPORTING  PERSONS  I.R.S.  IDENTIFICATION  NOS. OF
     ABOVE  PERSONS  (ENTITIES ONLY)
                              James Shawn Chalmers
----------------------------------------------------------------

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

         (a)   [_]
         (b)   [X]
----------------------------------------------------------------

3    SEC USE ONLY
----------------------------------------------------------------

4    SOURCE OF FUNDS*                          AF, WC
----------------------------------------------------------------

5    CHECK BOX IF DISCLOSURE OF LEGAL  PROCEEDINGS IS REQUIRED
     PURSUANT TO ITEM 2(d) or 2(e)    [_]
----------------------------------------------------------------

6    CITIZENSHIP OR PLACE OF ORGANIZATION
                              United States
----------------------------------------------------------------

NUMBER OF             7.  SOLE VOTING POWER:                   0
SHARES BENE-
FICIALLY              8.  SHARED VOTING POWER            596,000
OWNED BY
EACH REPORT-          9.  SOLE DISPOSITIVE POWER:              0
ING PERSON
WITH                 10.  SHARED DISPOSITIVE POWER       596,000
----------------------------------------------------------------

11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                                          596,000
----------------------------------------------------------------

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
     CERTAIN SHARES*           [_]
----------------------------------------------------------------

    13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                                         5.44%
----------------------------------------------------------------

    14      TYPE OF REPORTING PERSON*
                                         IN
----------------------------------------------------------------


                                       2




Item 1. Security and Issuer.

     (a) This  Statement  on Schedule  13D relates to the Common  Stock,  no par
value (the "Common  Stock"),  of Aspyra,  Inc., a  California  corporation  (the
"Company").

     (b) The principal  executive  offices of the Company are located at 26115-A
Mureau Road, Calabasas, California 91302.


Item 2. Identity and Background.

     (a) This  Statement on Schedule 13D is being filed by James Shawn  Chalmers
(the  "Reporting  Person").  The Reporting  Person does not own any Common Stock
directly.  The  Reporting  Person (i) is the sole  director  and  President  and
majority stockholder of J&S Ventures, Inc. ("J&S"), a Missouri corporation; (ii)
the sole manager and holder of 75% of the membership  interests of Orion Capital
Investments,  LLC ("Orion"),  a Missouri limited liability company; and the sole
trustee and sole  beneficiary  (during his  lifetime)  of the J. Shawn  Chalmers
Revocable Trust dated August 13, 1996 (the "Chalmers  Trust").  By virtue of his
positions with and/or equity  ownership of, such entities,  the Reporting Person
may be  deemed  to  control  each  of J&S,  Orion  and the  Chalmers  Trust  and
beneficially own the Common Stock of the Company owned by such entities.

     (b) The  business  address of the  Reporting  Person is 705 S. 10th Street,
Blue Springs, Missouri 64015.

     (c) The Reporting  Person's  present  principal  occupation is President of
J&S. The principal  business of J&S is an  independent  distributor of parts and
components  for  equipment  to the  construction,  mining and oil field  service
industry.  The  address of J&S is 705 S. 10th  Street,  Blue  Springs,  Missouri
64015.

     (d)-(e)  During  the last five  years,  the  Reporting  Person has not been
convicted in any criminal  proceeding  (excluding  traffic violations or similar
misdemeanors)  nor during that time has the  Reporting  Person been a party to a
civil proceeding of a judicial or administrative body of competent  jurisdiction
which  resulted in a judgment,  decree or final order  enjoining  the  Reporting
Person from future violations of, or prohibiting or mandating activities subject
to,  federal  or state  securities  laws or any  finding of any  violation  with
respect to such laws.

     (f) The Reporting Person is a citizen of the United States of America.


Item 3. Source and Amount of Funds or Other Consideration.

     On September  16, 2005 J&S  expended  $9,345 of its  investment  capital to
purchase 3,500 shares of Common Stock.


                                       3




     Orion and the  Chalmers  Trust effect open market  purchases of  securities
primarily  through lines of credit or margin  accounts  maintained for them with
Harrington Bank and Southwest  Securities,  Inc., which may extend margin credit
to Orion and Chalmers  Trust as and when required to open or carry  positions in
the margin accounts,  subject to applicable  Federal margin  regulations,  stock
exchange rules and the firm's credit policies. In such instances,  the positions
held in the margin accounts are pledged as collateral security for the repayment
of debit balances in the accounts.

     The source of funds to pay the $400,000 and  $300,000  purchase  prices for
the purchases of Common Stock and warrants made by Orion and the Chalmers  Trust
on May 17,  2006 as  described  in Item 5 (c)(i) and Item  5(c)(ii)  herein were
advances from Harrington Bank under lines of credit maintained by such entities.


Item 4. Purpose of Transaction.

     The  Reporting  Person  (as  well as J&S,  Orion  and the  Chalmers  Trust)
acquired all of the shares of Common Stock reported herein as beneficially owned
by the Reporting Person for investment purposes only.

     Except as set forth herein,  the Reporting Person has no plans or proposals
which would relate to or result in:

     (a)  The acquisition by any person of additional securities of the Company,
          or the disposition of securities of the Company;

     (b)  An   extraordinary   corporate   transaction,   such   as  a   merger,
          reorganization  or  liquidation,  involving  the Company or any of its
          subsidiaries;

     (c)  A sale or  transfer  of a material  amount of assets of the Company or
          any of its subsidiaries;

     (d)  Any change in the present  board of  directors  or  management  of the
          Company,  including  any plans or  proposals  to change  the number or
          terms of directors or to fill any existing vacancies on the board;

     (e)  Any material change in the present  capitalization  or dividend policy
          of the Company;

     (f)  Any other  material  change in the  Company's  business  or  corporate
          structure;

     (g)  Changes in the Company's charter, by-laws or instruments corresponding
          thereto or other actions which may impede the  acquisition  of control
          of the Company by any person;


                                       4




     (h)  Causing a class of  securities  of the Company to be  delisted  from a
          national securities exchange or to cease to be authorized to be quoted
          in  an  inter-dealer   quotation  system  of  a  registered   national
          securities association;

     (i)  A class of equity  securities  of the Company  becoming  eligible  for
          termination  of  registration  pursuant  to  Section  12(g)(4)  of the
          Securities Exchange Act of 1934, as amended; or

     (j)  Any action similar to any of those enumerated above.

     The  Reporting  Person  reserves  the right from time to time to acquire or
dispose of shares of Common  Stock,  or to formulate  other  purposes,  plans or
proposals  regarding  the  Company  or  securities  of the  Company  held by the
Reporting Person to the extent deemed  advisable in light of general  investment
policies, market conditions and other factors.


Item 5.  Interest in Securities of the Issuer.

     (a)  As of  the  date  hereof,  the  Reporting  Person  may  be  deemed  to
beneficially own 596,000 shares of the Common Stock  representing  approximately
5.44% percentage of the Company's  outstanding Common Stock. This includes 3,500
shares of Common Stock  directly  owned by J & S; 209,000 shares of Common Stock
and currently  exercisable  warrants to purchase  120,000 shares of Common Stock
directly  owned by Orion;  and  173,500  shares of  Common  Stock and  currently
exercisable warrants to purchase 90,000 shares of Common Stock directly owned by
the Chalmers Trust.

     (b) The  Reporting  Person may be deemed to share with the entity  directly
owning such shares, the power to vote or to direct the vote of, and the power to
dispose or direct the  disposition of all of the shares of Common Stock reported
as beneficially owned by such Reporting Person.

     (c) (i) On May 17, 2006,  pursuant to a Common  Stock and Warrant  Purchase
Agreement with the Company dated as of May 4, 2006 (the  "Purchase  Agreement"),
Orion  purchased  directly from the Company for an aggregate  purchase  price of
$400,000,  an  aggregate  of  200,000  shares of Common  Stock and  warrants  to
purchase for $3.00 per share an aggregate of 120,000 shares of Common Stock. The
warrants are  exercisable  until May 17, 2009. In  connection  with the Purchase
Agreement the Company and Orion entered into a  Registration  Rights  Agreement,
dated as of May 4, 2006 (the  "Registration  Agreement")  pursuant  to which the
Company has agreed to file with the  Securities  and  Exchange  Commission  (the
"SEC") within 60 days after May 17, 2006 a registration  statement  covering the
resale by Orion of the  shares of Common  Stock and the  shares of Common  Stock
issuable to Orion upon exercise of the warrants  purchased by Orion  pursuant to
the Purchase Agreement and to use commercially  reasonable efforts to cause such
registration statement to become effective within 120 days after May 17, 2006.


                                       5




     (ii) On May 17,  2006,  pursuant to the  Purchase  Agreement,  the Chalmers
Trust  purchased  directly from the Company for an aggregate  purchase  price of
$300,000,  an  aggregate  of  150,000  shares of Common  Stock and  warrants  to
purchase for $3.00 per share an aggregate of 90,000 shares of Common Stock.  The
warrants are  exercisable  until May 17, 2009. In  connection  with the Purchase
Agreement  the Company and the  Chalmers  Trust  entered  into the  Registration
Agreement  pursuant  to which the Company has agreed to file with the SEC within
60 days after May 17, 2006 a registration  statement  covering the resale by the
Chalmers  Trust of the  shares of Common  Stock and the  shares of Common  Stock
issuable to the Chalmers Trust upon exercise of the warrants  purchased by Orion
pursuant to the Purchase Agreement and to use commercially reasonable efforts to
cause such registration  statement to become effective within 120 days after May
17, 2006.

     (iii) On May 22, 2006 Orion purchased in an open market  transaction  9,000
shares of Common  Stock at $2.25 per share (an  aggregate  of $20,250)  and paid
$364.75 as a commission for such purchase.

     Except as set forth  herein,  no  transactions  in the  Common  Stock  were
effected during the past sixty days by the Reporting Person.

     (d)  Not applicable.

     (e)  Not applicable.


Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to
        Securities of the Issuer.

     None


Item 7. Material to be Filed as Exhibits.

     1.   Common Stock and Warrant Purchase  Agreement,  dated May 4, 2006 among
          the Company, Orion and the Chalmers Trust Incorporated by reference to
          Exhibit 10.1 to the  Company's  Current  Report on Form 8-K filed with
          the SEC on May 18, 2006.


     2.   Registration  Rights  Agreement,  dated as of May 4,  2006  among  the
          Company,  Orion and the Chalmers  Trust.  Incorporated by reference to
          Exhibit 10.2 to the  Company's  Current  Report on Form 8-K filed with
          the SEC on May 18, 2006.





                                       6





                                    SIGNATURE

     After  reasonable  inquiry and to the best of my knowledge and belief,  the
undersigned  certifies that the information set forth in this statement is true,
complete and correct.

                                                     May 24, 2006
                                                     ------------
                                                     (Date)


                           /s/ James Shawn Chalmers
                           --------------------------
                             James Shawn Chalmers







                                       7